New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps

CME

A Breath of Fresh Air: New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit™

Physicians: Maximum of 1.00 Medical Knowledge MOC point

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit™

Released: September 30, 2022

Expiration: September 30, 2023

Neil Skolnik
Neil Skolnik, MD
Eileen Wang
Eileen Wang, MD, MPH

Pretest

Progress
1 2
Course Completed
1.

John is a 32-year-old man experiencing sinus pain and pressure that has lasted for more than 3 months along with a cough. Over the counter decongestants have not been helpful and otoscopic evaluation reveals signs of nasal polyps. Which of the following tests would be useful to confirm the diagnosis and determine the endotype of John’s nasal polyps? 

2.

Which of the following cytokines plays a key role in the pathophysiology of chronic rhinosinusitis with nasal polyps?

3.

Katie is a 43-year-old woman with a history of CRSwNP for 4 years and previous experience with childhood asthma. She has received two sinus surgeries and multiple courses of oral corticosteroids previously, including two in the last year. Katie is currently being treated with intranasal corticosteroids but is experiencing worsening symptoms, including loss of smell. Her lab results show increased eosinophils. Based on current evidence and guidelines, which of the following treatment options would you recommend to Katie?

4.

Which of the following results was seen in the phase 3 SINUS trials of dupilumab versus placebo as an add-on to momelasone furoate in patients with poorly controlled CRSwNP?